Taking this into account, a recombinant prodomain peptide of ADAM17 was synthesized and shown to be an effective and highly specific inhibitor of ADAM17 activity in sepsis and inflammation models [199] and a murine kidney fibrosis model [200]. Here, ADAM17 is linked to Sepsis.